ArticleJournal of virology2024

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.

Jérémy Brunet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.